References
- Adil MT, Rahman R, Whitelaw D, et al. SARS-CoV-2 and the pandemic of COVID-19. Postgrad Med J. 2021;97:110–116. doi:10.1136/postgradmedj-2020-138386.
- Organization WH. WHO director-general’s opening remarks at the media briefing on COVID-19 — 11 March 2020. 2020.
- Fowler N, Mendez Martinez NR, Pallares BV, Maldonado RS. Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine. Am J Ophthalmol Case Rep. 2021;23:101136. doi:10.1016/j.ajoc.2021.101136.
- Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–2615. doi:10.1056/NEJMoa2034577.
- Sahin U, Muik A, Vogler I, et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature. 2021;595:572–577. doi:10.1038/s41586-021-03653-6.
- Renisi G, Lombardi A, Stanzione M, Invernizzi A, Bandera A, Gori A. Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence? Int J Infect Dis. 2021;110:95–97. doi:10.1016/j.ijid.2021.07.035.
- Valenzuela DA, Groth S, Taubenslag KJ, Gangaputra S. Acute macular neuroretinopathy following Pfizer-BioNTech COVID-19 vaccination. Am J Ophthalmol Case Rep. 2021;24:101200. doi:10.1016/j.ajoc.2021.101200.
- Goyal M, Murthy SI, Annum S. Bilateral Multifocal choroiditis following COVID-19 vaccination. Ocul Immunol Inflamm. 2021;1–5. doi:10.1080/09273948.2021.1900877.
- Mambretti M, Huemer J, Torregrossa G, Ullrich M, Findl O, Casalino G. Acute Macular Neuroretinopathy Following Coronavirus Disease 2019 Vaccination. Ocul Immunol Inflamm. 2021;29(4):730–733. doi:10.1080/09273948.2021.1946567.
- Santovito LS, Pinna G. Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report. Inflamm Res. 2021;70:931–933. doi:10.1007/s00011-021-01476-9.
- Pichi F, Aljneibi S, Neri P, Hay S, Dackiw C, Ghazi NG. Association of ocular adverse events with inactivated COVID-19 vaccination in patients in Abu Dhabi. JAMA Ophthalmol. 2021;139:1131. doi:10.1001/jamaophthalmol.2021.3477.
- Maleki A, Look-Why S, Manhapra A, Foster CS. COVID-19 recombinant mRNA vaccines and serious ocular inflammatory side effects: real or coincidence? J Ophthalmic Vis Res. 2021;16:490–501. doi:10.18502/jovr.v16i3.9443.
- Mudie LI, Zick JD, Dacey MS, Palestine AG. Panuveitis following vaccination for COVID-19. Ocul Immunol Inflamm. 2021;29(4):741–742. doi:10.1080/09273948.2021.1949478.
- Mishra SB, Mahendradas P, Kawali A, Sanjay S, Shetty R. Reactivation of varicella zoster infection presenting as acute retinal necrosis post COVID 19 vaccination in an Asian Indian male. Eur J Ophthalmol. 2021 Sep 18:11206721211046485. doi:10.1177/11206721211046485.
- Sharma A, Kudchadkar US, Shirodkar R, Usgaonkar UPS, Naik A. Unilateral inferior altitudinal visual field defect related to COVID-19. Indian J Ophthalmol. 2021;69:989–991. doi:10.4103/ijo.IJO_3666_20.
- Sanjay S, Ponnuru D, Kumar S, Rao VK R, Kawali A, Mahendradas P. Herpes zoster reactivation after COVID-19 vaccination in patients with autoimmune diseases. Indian J Rheumatol. [Epub ahead of print] [cited 2022 Feb 12]. doi:10.4103/injr.injr_137_21.
- Kumar P, Kijima Y, West BH, Tobis JM. The connection between patent foramen ovale and migraine. Neuroimaging Clin N Am. 2019;29(2):261–270. doi:10.1016/j.nic.2019.01.006.
- Gold DM, Galetta SL. Neuro-ophthalmologic complications of coronavirus disease 2019 (COVID-19). Neurosci Lett. 2021;742:135531. doi:10.1016/j.neulet.2020.135531.